These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33459235)

  • 1. A Comparison of Neurocognitive Decline in Older Adults in Same-Sex and Opposite-Sex Relationships.
    Manca R; Venneri A
    Curr Alzheimer Res; 2020; 17(12):1102-1114. PubMed ID: 33459235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease.
    Dicks E; Vermunt L; van der Flier WM; Visser PJ; Barkhof F; Scheltens P; Tijms BM;
    Neuroimage Clin; 2019; 22():101786. PubMed ID: 30921610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease.
    van de Mortel LA; Thomas RM; van Wingen GA;
    J Alzheimers Dis; 2021; 83(2):705-720. PubMed ID: 34366336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
    Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
    J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grey matter atrophy in mild cognitive impairment / early Alzheimer disease associated with delusions: a voxel-based morphometry study.
    Ting WK; Fischer CE; Millikin CP; Ismail Z; Chow TW; Schweizer TA
    Curr Alzheimer Res; 2015; 12(2):165-72. PubMed ID: 25654501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling heterogeneity of Alzheimer's disease using white-matter impairment factors.
    Sui X; Rajapakse JC;
    Neuroimage Clin; 2018; 20():1222-1232. PubMed ID: 30412925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal progression of grey matter atrophy in non-amnestic Alzheimer's disease.
    Phillips JS; Da Re F; Irwin DJ; McMillan CT; Vaishnavi SN; Xie SX; Lee EB; Cook PA; Gee JC; Shaw LM; Trojanowski JQ; Wolk DA; Grossman M
    Brain; 2019 Jun; 142(6):1701-1722. PubMed ID: 31135048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamics of brain structure and cognitive function in the Alzheimer's disease neuroimaging initiative.
    Song X; Mitnitski A; Zhang N; Chen W; Rockwood K;
    J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):71-8. PubMed ID: 23123510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the association between brain atrophy, hypometabolism, and cognitive decline in Alzheimer's disease: a PET/MRI study.
    Chen Y; Wang J; Cui C; Su Y; Jing D; Wu L; Liang P; Liang Z
    Aging (Albany NY); 2021 Feb; 13(5):7228-7246. PubMed ID: 33640881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
    Weiler M; Agosta F; Canu E; Copetti M; Magnani G; Marcone A; Pagani E; Balthazar ML; Comi G; Falini A; Filippi M
    J Alzheimers Dis; 2015; 47(4):995-1007. PubMed ID: 26401778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia.
    Dadar M; Manera AL; Ducharme S; Collins DL
    Neurobiol Aging; 2022 Mar; 111():54-63. PubMed ID: 34968832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomical correlates of the neuropsychiatric symptoms in Alzheimer's disease.
    Hu X; Meiberth D; Newport B; Jessen F
    Curr Alzheimer Res; 2015; 12(3):266-77. PubMed ID: 25731626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Likelihood of Dementia with Coexisting Atrophy of Multiple Regions of Interest.
    Kim REY; Lee M; Kang DW; Wang SM; Kim D; Lim HK
    J Alzheimers Dis; 2024; 97(1):259-271. PubMed ID: 38143346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study.
    Zhang N; Song X; Zhang Y; Chen W; D'Arcy RC; Darvesh S; Fisk JD; Rockwood K;
    J Alzheimers Dis; 2011; 26 Suppl 3():359-67. PubMed ID: 21971475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer's Disease.
    Kimura A; Yoshikura N; Hayashi Y; Inuzuka T
    J Alzheimers Dis; 2018; 61(2):581-588. PubMed ID: 29171996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More atrophy of deep gray matter structures in frontotemporal dementia compared to Alzheimer's disease.
    Möller C; Dieleman N; van der Flier WM; Versteeg A; Pijnenburg Y; Scheltens P; Barkhof F; Vrenken H
    J Alzheimers Dis; 2015; 44(2):635-47. PubMed ID: 25322925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.